Central Trust Company’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-804
Closed -$16.4K 1236
2023
Q1
$16.4K Buy
+804
New +$16.2K ﹤0.01% 970

Other funds holding BTAL

Central Trust Company's BTAL Position: Q2 2023 in Review

Central Trust Company sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 804 shares — an estimated $16.4K sold.

Central Trust Company first reported a position in BTAL in Q1 2023 and held it in 1 quarter. The position peaked at $16.4K in Q1 2023. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Central Trust Company reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Central Trust Company sold 804 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $16.4K.
  • Central Trust Company first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 1 quarter.
  • Central Trust Company's AGF US Market Neutral Anti-Beta Fund position peaked at $16.4K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Central Trust Company's 13F filing for Q2 2023, filed 26 Jul 2023.